PSYMED VENTURES
Psymed Ventures is an investment syndicate that invests in early-stage psychedelics companies. The firm was founded in 2020 by Matias Serebrinsky and Dina Burkitbayeva and is headquartered in San Francisco, California, United States.
PSYMED VENTURES
Industry:
Finance Financial Services Venture Capital
Founded:
2020-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Global Site Tag
Similar Organizations
Alumni Ventures
Alumni Ventures Group provides diversified venture portfolios to individual investors who previously haven't had access to VC.
One Way Ventures
One Way Ventures is a seed-stage fund that invests in immigrant tech founders.
W Health Ventures
W Health Ventures invests in digital health companies that are transforming healthcare delivery.
Current Employees Featured
Razi Syed
Razi Syed Associate @ PsyMed Ventures Associate 2022-03-07
Matias Serebrinsky
Matias Serebrinsky Co-founder and General Partner @ PsyMed Ventures Co-founder and General Partner 2020-09-01
Greg Kubin
Greg Kubin Founder @ PsyMed Ventures Founder 2020-07-01
Dina Burkitbayeva
Dina Burkitbayeva General Partner @ PsyMed Ventures General Partner
Garri Zmudze
Garri Zmudze Venture Partner @ PsyMed Ventures Venture Partner 2022-07-01
Founder
Dina Burkitbayeva
Greg Kubin
Matias Serebrinsky
Investors List
DWS Holdings Inc.
DWS Holdings Inc. investment in Venture Round - PsyMed Ventures
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-08-23 | Freedom Biosciences | PsyMed Ventures investment in Seed Round - Freedom Biosciences | 10.5 M USD |
2021-09-27 | Delix Therapeutics | PsyMed Ventures investment in Series A - Delix Therapeutics | 70 M USD |
2021-09-16 | Journey Clinical | PsyMed Ventures investment in Seed Round - Journey Clinical | 3 M USD |
2021-06-25 | TRIPP | PsyMed Ventures investment in Series A - TRIPP | 11 M USD |